Woyach, J.A.; Barr, P.M.; Kipps, T.J.; Barrientos, J.C.; Ahn, I.E.; Ghia, P.; Girardi, V.; Hsu, E.; Jermain, M.; Burger, J.A.
Characteristics and Clinical Outcomes of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receiving Ibrutinib for ≥5 Years in the RESONATE-2 Study. Cancers 2023, 15, 507.
https://doi.org/10.3390/cancers15020507
AMA Style
Woyach JA, Barr PM, Kipps TJ, Barrientos JC, Ahn IE, Ghia P, Girardi V, Hsu E, Jermain M, Burger JA.
Characteristics and Clinical Outcomes of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receiving Ibrutinib for ≥5 Years in the RESONATE-2 Study. Cancers. 2023; 15(2):507.
https://doi.org/10.3390/cancers15020507
Chicago/Turabian Style
Woyach, Jennifer A., Paul M. Barr, Thomas J. Kipps, Jacqueline C. Barrientos, Inhye E. Ahn, Paolo Ghia, Vincent Girardi, Emily Hsu, Mandy Jermain, and Jan A. Burger.
2023. "Characteristics and Clinical Outcomes of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receiving Ibrutinib for ≥5 Years in the RESONATE-2 Study" Cancers 15, no. 2: 507.
https://doi.org/10.3390/cancers15020507
APA Style
Woyach, J. A., Barr, P. M., Kipps, T. J., Barrientos, J. C., Ahn, I. E., Ghia, P., Girardi, V., Hsu, E., Jermain, M., & Burger, J. A.
(2023). Characteristics and Clinical Outcomes of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receiving Ibrutinib for ≥5 Years in the RESONATE-2 Study. Cancers, 15(2), 507.
https://doi.org/10.3390/cancers15020507
